TY - JOUR
T1 - Adverse reactions to fluorescein angiography
T2 - A comprehensive review of the literature
AU - Kornblau, Ilyse S.
AU - El-Annan, Jaafar F.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - We reviewed literature on adverse reactions to intravenous fluorescein angiography using PubMed and found 78 articles in English from 1961 to 2017. The reported rates of adverse reactions were overall 0.083–21.69%, separated into mild (1.24–17.65%), moderate (0.2–6%), and severe (0.04–0.59%). There were 1:100,000 to 1:220,000 deaths. Fluorescein concentration, volume injected, speed of injection, temperature, and contaminants were not correlated with the incidence of reactions. Patient characteristics including other comorbid diseases, allergy history, age, race, and gender showed only an increased rate of reaction in patients with a history of reaction to fluorescein. Although a number of studies examine techniques to reduce adverse reactions to intravenous fluorescein angiography, to date, the only proven method is reviewing allergy history, specifically a history of previous reaction to fluorescein.
AB - We reviewed literature on adverse reactions to intravenous fluorescein angiography using PubMed and found 78 articles in English from 1961 to 2017. The reported rates of adverse reactions were overall 0.083–21.69%, separated into mild (1.24–17.65%), moderate (0.2–6%), and severe (0.04–0.59%). There were 1:100,000 to 1:220,000 deaths. Fluorescein concentration, volume injected, speed of injection, temperature, and contaminants were not correlated with the incidence of reactions. Patient characteristics including other comorbid diseases, allergy history, age, race, and gender showed only an increased rate of reaction in patients with a history of reaction to fluorescein. Although a number of studies examine techniques to reduce adverse reactions to intravenous fluorescein angiography, to date, the only proven method is reviewing allergy history, specifically a history of previous reaction to fluorescein.
KW - adverse reactions
KW - allergy
KW - anaphylaxis
KW - drug toxicity
KW - fluorescein angiography
KW - medication reactions
UR - http://www.scopus.com/inward/record.url?scp=85065066266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065066266&partnerID=8YFLogxK
U2 - 10.1016/j.survophthal.2019.02.004
DO - 10.1016/j.survophthal.2019.02.004
M3 - Article
C2 - 30772364
AN - SCOPUS:85065066266
SN - 0039-6257
VL - 64
SP - 679
EP - 693
JO - Survey of Ophthalmology
JF - Survey of Ophthalmology
IS - 5
ER -